Benzinga - 13 hours ago
Benzinga - 16 hours ago
Benzinga - 1 day ago
Benzinga - May 13, 2021, 7:17AM
Benzinga - May 13, 2021, 7:13AM
Benzinga - Apr 8, 2021, 6:23AM
Benzinga - Mar 29, 2021, 4:31PM
Benzinga - Mar 29, 2021, 4:18PM
Benzinga - Mar 3, 2021, 9:25AM
Benzinga - Mar 3, 2021, 8:49AM
Benzinga - Mar 2, 2021, 1:26PM
Benzinga - Mar 2, 2021, 1:22PM
Benzinga - Feb 10, 2021, 12:07PM
Benzinga - Feb 10, 2021, 7:21AM
load more
Sector: Health Care.Industry: Biotechnology
Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel therapeutic compounds to treat genetically defined AMD. Its candidate, GEM103, is a recombinant form of the Complement Factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health. Variations in the gene that encodes CFH strongly correlate with an increased risk of developing AMD.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-1.180-0.590 0.5900
REV0
FY 2020Est.ActualSurprise
EPS-0.250
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GMTXGemini Therapeutics3.14%

Gemini Therapeutics Frequently Asked Questions

Q

How do I buy Gemini Therapeutics (GMTX) stock?

A

You can purchase shares of Gemini Therapeutics (NASDAQ: GMTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Gemini Therapeutics's (GMTX) competitors?

A

Other companies in Gemini Therapeutics’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Amgen (NASDAQ:AMGN), BioNTech (NASDAQ:BNTX) and Natera (NASDAQ:NTRA).

Q

What is the target price for Gemini Therapeutics (GMTX) stock?

A

The latest price target for Gemini Therapeutics (NASDAQ: GMTX) was reported by SVB Leerink on April 8, 2021. The analyst firm set a price target for 25.00 expecting GMTX to rise to within 12 months (a possible 273.69% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Gemini Therapeutics (GMTX)?

A

The stock price for Gemini Therapeutics (NASDAQ: GMTX) is $6.69 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Gemini Therapeutics (GMTX) pay a dividend?

A

There are no upcoming dividends for Gemini Therapeutics.

Q

When is Gemini Therapeutics (NASDAQ:GMTX) reporting earnings?

A
Gemini Therapeutics’s Q2 earnings are confirmed for after-market on September 15, 2021.
Q

Is Gemini Therapeutics (GMTX) going to split?

A

There is no upcoming split for Gemini Therapeutics.

Q

What sector and industry does Gemini Therapeutics (GMTX) operate in?

A

Gemini Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.